Non-invasive vagus nerve stimulation for treatment of cluster headache: early UK clinical experience.

ABSTRACT:

Background

Evidence supports the use of non-invasive vagus nerve stimulation (nVNS; gammaCore®) as a promising therapeutic option for patients with cluster headache (CH). We conducted this audit of real-world data from patients with CH, the majority of whom were treatment refractory, to explore early UK clinical experience with nVNS used acutely, preventively, or both.

Methods

We retrospectively analysed data from 30 patients with CH (29 chronic, 1 episodic) who submitted individual funding requests for nVNS to the National Health Service. All patients had responded to adjunctive nVNS therapy during an evaluation period (typical duration, 3-6 months). Data collected from patient interviews, treatment diaries, and physician notes were summarised with descriptive statistics. P

SUBMITTER: Marin J 

PROVIDER: S-EPMC6755582 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature